Skip to main content

Table 2 T5SS and RQLQ Overall Score at 4 Weeks

From: Persistent Allergic Rhinitis and the XPERT Study

Treatment Group

N*

Baseline/Mean (SD)

After 4 Weeks of Treatment/Adjusted Mean (SEM)†

Difference vs Placebo (95% CI)/Adjusted Mean

P

RQLQ overall score

     

   Placebo

252

3.06 (0.94)

−1.01 (0.07)

  

   Levocetirizine (5 mg)

257

3.04 (0.92)

−1.49 (0.07)

0.48 (0.29-0.67)

<0.001

T5SS

     

   Placebo

271

8.90 (2.26)

−2.40 (0.15)

  

   Levocetirizine (5 mg)

276

9.02 (2.28)

−3.54 (0.15)

1.14 (0.75-1.52)

<0.001

  1. *Number of ITT patients with nonmissing values at baseline and under treatment.
  2. †Mean change from baseline, adjusted for baseline score and country.
Back to article page

World Allergy Organization Journal

ISSN: 1939-4551

Contact us